CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-122272 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 24, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
245,518
Total Value
$468,735.60
P&L
+inf% (+$8,972,673.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Mar 20, 2026 | Exercise/Conversion | 19,687 | โ | โ | 265,521 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 23, 2026 | Sale | 10,020 | $46.78 | $468,735.60 | 255,501 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 20, 2026 | Grant/Award | 114,249 | $0.00 | $0.00 | 114,249 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Mar 20, 2026 | Grant/Award | 81,875 | $0.00 | $0.00 | 81,875 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Mar 20, 2026 | Exercise/Conversion | 19,687 | โ | โ | 39,375 | Direct | โ | View Details |